Anticoagulant Therapy During Pacemaker Implantation

PHASE4CompletedINTERVENTIONAL
Enrollment

447

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
HemorrhageThrombosisEmbolism
Interventions
DRUG

Warfarin

Warfarin is either interrupted or uninterrupted prior to device implantation

DRUG

Aspirin

Aspirin is continued without interruption prior to device implantation

DEVICE

Permanent pacemaker

Devices are implanted tailored each patient's clinical condition and need following local practices, national and international guidelines.

DEVICE

Implantable Cardioverter-defibrillator

Devices are implanted tailored each patient's clinical condition and need following local practices, national and international guidelines.

Trial Locations (1)

20521

Turku University Hospital, Turku

All Listed Sponsors
collaborator

Satakunta Central Hospital

OTHER

collaborator

Oulu University Hospital

OTHER

collaborator

Tampere University Hospital

OTHER

lead

University of Turku

OTHER

NCT00479362 - Anticoagulant Therapy During Pacemaker Implantation | Biotech Hunter | Biotech Hunter